Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma.

Cancer chemotherapy and biological response modifiers

Volumn 22, Issue , 2005, Pages 789-797

  Albertini, Mark R ^a   Hank, Jacquelyn A ^a   Sondel, Paul M ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; GANGLIOSIDE; INTERLEUKIN 2; MONOCLONAL ANTIBODY; SIALOGANGLIOSIDES;

HUMAN; IMMUNOLOGY; MELANOMA; REVIEW; SKIN TUMOR;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; GANGLIOSIDES; HUMANS; INTERLEUKIN-2; MELANOMA; SKIN NEOPLASMS;

MLCS; MLOWN;

EID: 25444439871     PISSN: 09214410     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0921-4410(04)22037-3     Document Type: Review

References (30)